Keiko Iwata
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Keiko Iwata has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Nori Takei
Research Center for Child Mental Development, United Graduate School of Child Development, Institute of Psychiatry, King’s College London, London, UK
4 shared publications - Norio Mori
Research Center for Child Mental Development, Hamamatsu University School of Medicine, Hamamatsu, Japan
4 shared publications Hideo Matsuzaki
3 shared publications- Hideo Matsuzaki
Department of Functional Brain Activities, United Graduate School of Child Development, University of Osaka, Suita 565-0871, Osaka, Japan
3 shared publications - Katsuaki Suzuki
Department of Psychiatry and Neurology, Hamamatsu University School of Medicine, Hamamatsu, Japan
3 shared publications - Chie Shimmura
Department of Psychiatry, Hamamatsu University School of Medicine, Hamamatsu, Japan
2 shared publications
Latest Publications
- 1 April 2012
- Published by Elsevier in Schizophrenia Research
- Vol. 136, S286
Poster #16 ALTERATION OF SEVERAL SCHIZOPHRENIA CANDIDATE GENES EXPRESSION IN MEDIAL PREFRONTAL CORTEX IN PERINATAL ASPHYXIA RODENTMODEL
- 1 April 2012
- Published by Elsevier in Schizophrenia Research
- Vol. 136, S286
Poster #16 ALTERATION OF SEVERAL SCHIZOPHRENIA CANDIDATE GENES EXPRESSION IN MEDIAL PREFRONTAL CORTEX IN PERINATAL ASPHYXIA RODENTMODEL
- 1 December 2011
- Published by Elsevier in Psychiatry Research
- Vol. 190 (2-3) , 364-366
Altering the expression balance of hnRNP C1 and C2 changes the expression of myelination-related genes
- 1 December 2011
- Published by Elsevier in Psychiatry Research
- Vol. 190 (2-3) , 364-366
Altering the expression balance of hnRNP C1 and C2 changes the expression of myelination-related genes
- Open Access
- 19 October 2011
- Published by Springer Nature in Molecular Autism
- Vol. 2 (1) , 16
Investigation of the serum levels of anterior pituitary hormones in male children with autism
Background: The neurobiological basis of autism remains poorly understood. The diagnosis of autism is based solely on behavioural characteristics because there are currently no reliable biological markers. To test whether the anterior pituitary hormones and cortisol could be useful as biological markers for autism, we assessed the basal serum levels of these hormones in subjects with autism and normal controls. Findings: Using a suspension array system, we determined the serum levels of six anterior pituitary hormones, including adrenocorticotropic hormone and growth hormone, in 32 drug-naive subjects (aged 6 to 18 years, all boys) with autism, and 34 healthy controls matched for age and gender. We also determined cortisol levels in these subjects by enzyme-linked immunosorbent assay. Serum levels of adrenocorticotropic hormone, growth hormone and cortisol were significantly higher in subjects with autism than in controls. In addition, there was a significantly positive correlation between cortisol and adrenocorticotropic hormone levels in autism. Conclusion: Our results suggest that increased basal serum levels of adrenocorticotropic hormone accompanied by increased cortisol and growth hormone may be useful biological markers for autism.
- 19 October 2011
- Published by Springer Nature in Molecular Autism
- Vol. 2 (1) , 16
Open AccessInvestigation of the serum levels of anterior pituitary hormones in male children with autism
Background: The neurobiological basis of autism remains poorly understood. The diagnosis of autism is based solely on behavioural characteristics because there are currently no reliable biological markers. To test whether the anterior pituitary hormones and cortisol could be useful as biological markers for autism, we assessed the basal serum levels of these hormones in subjects with autism and normal controls. Findings: Using a suspension array system, we determined the serum levels of six anterior pituitary hormones, including adrenocorticotropic hormone and growth hormone, in 32 drug-naive subjects (aged 6 to 18 years, all boys) with autism, and 34 healthy controls matched for age and gender. We also determined cortisol levels in these subjects by enzyme-linked immunosorbent assay. Serum levels of adrenocorticotropic hormone, growth hormone and cortisol were significantly higher in subjects with autism than in controls. In addition, there was a significantly positive correlation between cortisol and adrenocorticotropic hormone levels in autism. Conclusion: Our results suggest that increased basal serum levels of adrenocorticotropic hormone accompanied by increased cortisol and growth hormone may be useful biological markers for autism.
- Open Access
- 1 January 2011
- Published by Springer Nature in Molecular Autism
- Vol. 2 (1) , 14
Decreased expression of axon-guidance receptors in the anterior cingulate cortex in autism
Axon-guidance proteins play a crucial role in brain development. As the dysfunction of axon-guidance signaling is thought to underlie the microstructural abnormalities of the brain in people with autism, we examined the postmortem brains of people with autism to identify any changes in the expression of axon-guidance proteins. The mRNA and protein expression of axon-guidance proteins, including ephrin (EFN)A4, eEFNB3, plexin (PLXN)A4, roundabout 2 (ROBO)2 and ROBO3, were examined in the anterior cingulate cortex and primary motor cortex of autistic brains (n = 8 and n = 7, respectively) and control brains (n = 13 and n = 8, respectively) using real-time reverse-transcriptase PCR (RT-PCR) and western blotting. Real-time RT-PCR revealed that the relative expression levels of EFNB3, PLXNA4A and ROBO2 were significantly lower in the autistic group than in the control group. The protein levels of these three genes were further analyzed by western blotting, which showed that the immunoreactive values for PLXNA4 and ROBO2, but not for EFNB3, were significantly reduced in the ACC of the autistic brains compared with control brains. In this study, we found decreased expression of axon-guidance proteins such as PLXNA4 and ROBO2 in the brains of people with autism, and suggest that dysfunctional axon-guidance protein expression may play an important role in the pathophysiology of autism.
- 1 January 2011
- Published by Springer Nature in Molecular Autism
- Vol. 2 (1) , 14
Open AccessDecreased expression of axon-guidance receptors in the anterior cingulate cortex in autism
Axon-guidance proteins play a crucial role in brain development. As the dysfunction of axon-guidance signaling is thought to underlie the microstructural abnormalities of the brain in people with autism, we examined the postmortem brains of people with autism to identify any changes in the expression of axon-guidance proteins. The mRNA and protein expression of axon-guidance proteins, including ephrin (EFN)A4, eEFNB3, plexin (PLXN)A4, roundabout 2 (ROBO)2 and ROBO3, were examined in the anterior cingulate cortex and primary motor cortex of autistic brains (n = 8 and n = 7, respectively) and control brains (n = 13 and n = 8, respectively) using real-time reverse-transcriptase PCR (RT-PCR) and western blotting. Real-time RT-PCR revealed that the relative expression levels of EFNB3, PLXNA4A and ROBO2 were significantly lower in the autistic group than in the control group. The protein levels of these three genes were further analyzed by western blotting, which showed that the immunoreactive values for PLXNA4 and ROBO2, but not for EFNB3, were significantly reduced in the ACC of the autistic brains compared with control brains. In this study, we found decreased expression of axon-guidance proteins such as PLXNA4 and ROBO2 in the brains of people with autism, and suggest that dysfunctional axon-guidance protein expression may play an important role in the pathophysiology of autism.
- 31 January 2010
- Published by Elsevier in Process Biochemistry
- Vol. 45 (1) , 54-59
Novel events in mitchondria: Increase of poly(ADP-ribosyl)ation in human promyelocytic leukemia HL-60 cell line during differentiation by nicotinamide
- 31 January 2010
- Published by Elsevier in Process Biochemistry
- Vol. 45 (1) , 54-59
Novel events in mitchondria: Increase of poly(ADP-ribosyl)ation in human promyelocytic leukemia HL-60 cell line during differentiation by nicotinamide
- Open Access
- 1 January 2010
- Published by SAGE Publications in Journal of Central Nervous System Disease
- Vol. 2, 37-44
Animal Models of Autism: An Epigenetic and Environmental Viewpoint
Autism is a neurodevelopmental disorder of social behavior, which is more common in males than in females. The causes of autism are unknown; there is evidence for a substantial genetic component, but it is likely that a combination of genetic, environmental and epigenetic factors contribute to its complex pathogenesis. Rodent models that mimic the behavioral deficits of autism can be useful tools for dissecting both the etiology and molecular mechanisms. This review discusses animal models of autism generated by prenatal or neonatal environmental challenges, including virus infection and exposure to valproic acid (VPA) or stress. Studies of viral infection models suggest that interleukin-6 can influence fetal development and programming. Prenatal exposure to the histone deacetylase inhibitor VPA has been linked to autism in children, and male VPA-exposed rats exhibit a spectrum of autistic-like behaviors. The experience of prenatal stress produces male-specific behavioral abnormalities in rats. These effects may be mediated by epigenetic modifications such as DNA methylation and histone acetylation resulting in alterations to the transcriptome.
- 1 January 2010
- Published by SAGE Publications in Journal of Central Nervous System Disease
- Vol. 2, 37-44
Open AccessAnimal Models of Autism: An Epigenetic and Environmental Viewpoint
Autism is a neurodevelopmental disorder of social behavior, which is more common in males than in females. The causes of autism are unknown; there is evidence for a substantial genetic component, but it is likely that a combination of genetic, environmental and epigenetic factors contribute to its complex pathogenesis. Rodent models that mimic the behavioral deficits of autism can be useful tools for dissecting both the etiology and molecular mechanisms. This review discusses animal models of autism generated by prenatal or neonatal environmental challenges, including virus infection and exposure to valproic acid (VPA) or stress. Studies of viral infection models suggest that interleukin-6 can influence fetal development and programming. Prenatal exposure to the histone deacetylase inhibitor VPA has been linked to autism in children, and male VPA-exposed rats exhibit a spectrum of autistic-like behaviors. The experience of prenatal stress produces male-specific behavioral abnormalities in rats. These effects may be mediated by epigenetic modifications such as DNA methylation and histone acetylation resulting in alterations to the transcriptome.